PODs can be utilized in a multitude of applications including: monoclonal antibodies, vaccine or recombinant proteins, personalized medicines, cell and gene therapy  and even laboratory use.  The utlization of single-use processing equipment within the POD creates the most flexible production platform available.  PODs can either be dedicated to a process step or employed as a small volume total process containment solution, involving either glove boxes or isolators within the POD. 

 

Since PODs can be easily decontaminated, POD processes can be used for multi-product purposes.

 

The different sizes and customizable options make PODs a solution for every product development stage.

 

In addition, PODs are repurposeable which allows them to be leased, re-used and/or sold.

PODs for Bioprocessing Needs

 

MONOCLONAL ANTIBODY | CELL BASED VACCINE | RECOMBINANT PROTEIN

Benefit Case

• Rapid construction period in approx. 8 months (iCON systems can be fully delivered in 12 months)

• Lower cost of capital

• Ability to use pre-existing space

• Easily expandable

• Processes modified, highly flexible

• Capable of multi-product campaigns per year

PODs for Personalized Medicine

 

CELL THERAPY | GENE THERAPY | AUTOLOGOUS VACCINE

Benefit Case

• Scaling without interruption

• Opportunity to delay time to investment

• Unidirectional flow and corridor incorporated

• Requires only large "gray space"

• Multi-product processing

PODs for Fill Finish

 

FILL FINISH | ASEPTIC PROCESSING | FILLING SUITES

Benefit Case

• Designed for any manufacturer’s aseptic processing and filling equipment

• Rapid installation in existing or new building

• Fill suites can be added to increase capacity with minimal interruption to operations

• Accommodates component preparation operations and/or pre-sterilized ready to use components

• Ideal for containment needed for processing and filling of High Potent Compounds

PODs for Laboratory Space and Containment

 

MICROBIAL | ANALYTICAL | ASSAY

Benefit Case

• Easy expansion of new and existing laboratory infrastructure

• Can be repurposed and reused as processes move from R&D scale to commercial scale

• Self-contained, self sufficient for a broad range of air qualities and BSLs.